MidCap Financial Investment Corporation 8.00% Notes due 2028 represents an attractive fixed-income opportunity for institutional investors seeking exposure to the healthcare finance sector. By focusing on middle-market healthcare organizations, the company provides specialized financial solutions that enhance growth and sustainability, supported by a competitive 8.00% yield. Set to mature in 2028, these notes are anchored by a well-diversified portfolio, allowing MidCap Financial to deliver stable returns even in volatile markets. Backed by an experienced management team skilled in the healthcare landscape, MidCap Financial is well-positioned to leverage emerging opportunities while mitigating risks.
| Revenue (TTM) | $271.69M |
| Gross Profit (TTM) | $271.69M |
| EBITDA | — |
| Operating Margin | 79.50% |
| Return on Equity | 0.00% |
| Return on Assets | 0.00% |
| Revenue/Share (TTM) | $4.14 |
| Book Value | — |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 85.90% |
| Quarterly Revenue Growth (YoY) | 15.80% |
| Shares Outstanding | 0 |
| Float | 0 |
| % Insiders | 0.00% |
| % Institutions | 0.00% |
Volatility is currently contracting